rs71873106

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The ENST00000379079.8(WT1):​c.-8_-7delGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00396 in 1,608,994 control chromosomes in the GnomAD database, including 225 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 114 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 111 hom. )

Consequence

WT1
ENST00000379079.8 5_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.880

Publications

0 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1 Gene-Disease associations (from GenCC):
  • Denys-Drash syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • Wilms tumor 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Frasier syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-32430545-AGC-A is Benign according to our data. Variant chr11-32430545-AGC-A is described in ClinVar as Benign. ClinVar VariationId is 257619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0718 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WT1NM_024426.6 linkc.662-1928_662-1927delGC intron_variant Intron 1 of 9 ENST00000452863.10 NP_077744.4 P19544-7Q6PI38

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WT1ENST00000452863.10 linkc.662-1928_662-1927delGC intron_variant Intron 1 of 9 1 NM_024426.6 ENSP00000415516.5 P19544-7A0A0A0MT54

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
3139
AN:
149700
Hom.:
114
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0742
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000418
Gnomad FIN
AF:
0.000195
Gnomad MID
AF:
0.00325
Gnomad NFE
AF:
0.000236
Gnomad OTH
AF:
0.0224
GnomAD2 exomes
AF:
0.00476
AC:
1138
AN:
239094
AF XY:
0.00356
show subpopulations
Gnomad AFR exome
AF:
0.0702
Gnomad AMR exome
AF:
0.00344
Gnomad ASJ exome
AF:
0.000304
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000938
Gnomad NFE exome
AF:
0.000198
Gnomad OTH exome
AF:
0.00271
GnomAD4 exome
AF:
0.00221
AC:
3232
AN:
1459184
Hom.:
111
AF XY:
0.00196
AC XY:
1420
AN XY:
725746
show subpopulations
African (AFR)
AF:
0.0772
AC:
2578
AN:
33406
American (AMR)
AF:
0.00426
AC:
190
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39632
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
85824
European-Finnish (FIN)
AF:
0.0000768
AC:
4
AN:
52082
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5764
European-Non Finnish (NFE)
AF:
0.000143
AC:
159
AN:
1111442
Other (OTH)
AF:
0.00448
AC:
270
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
156
312
467
623
779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0210
AC:
3139
AN:
149810
Hom.:
114
Cov.:
32
AF XY:
0.0206
AC XY:
1505
AN XY:
73190
show subpopulations
African (AFR)
AF:
0.0741
AC:
2979
AN:
40224
American (AMR)
AF:
0.00627
AC:
94
AN:
14984
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4992
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4776
European-Finnish (FIN)
AF:
0.000195
AC:
2
AN:
10260
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000236
AC:
16
AN:
67824
Other (OTH)
AF:
0.0221
AC:
46
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
140
281
421
562
702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
8
Bravo
AF:
0.0236
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Frasier syndrome Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meacham syndrome Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrotic syndrome, type 4 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Drash syndrome Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Wilms tumor 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.88
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71873106; hg19: chr11-32452091; COSMIC: COSV104651942; API